NIH study identifies gene that suppresses cell’s immune activation

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

The Journal of Clinical Investigation has retracted the article, "FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer